Canadian drugmaker Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash. The companies said Sunday that their boards of directors approved the transaction, which amounts to about $158 per share in Salix stock. With debt,…
Source:Valeant agrees to buy Salix for about $10 billion in cash
Sunday, February 22, 2015
Valeant agrees to buy Salix for about $10 billion in cash
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment